JANUET 50/850 MG TABLETS
Land: Israel
Sprog: engelsk
Kilde: Ministry of Health
Nogle dokumenter til dette produkt er ikke tilgængelige i øjeblikket, du kan sende en anmodning til vores kundeservice, og vi vil underrette dig, så snart vi er i stand til at få dem.
Send anmodning.
Send anmodning.
Aktiv bestanddel:
METFORMIN HYDROCHLORIDE 850 MG; SITAGLIPTIN AS MONOHYDRATE PHOSPHATE 50 MG
Tilgængelig fra:
MERCK SHARP & DOHME ISRAEL LTD
ATC-kode:
A10BA02
Lægemiddelform:
TABLETS
Indgivelsesvej:
PER OS
Fremstillet af:
MERCK SHARP & DOHME CORP., USA
Terapeutisk gruppe:
METFORMIN
Terapeutiske indikationer:
Januet is indicated as an adjunct to diet and exercise to improve glycemic control in adult patients with type 2 diabetes mellitus. Important limitations of use:Januet should not be used in patients with type 1 diabetes or for the treatment of diabetic ketoacidosis, as it would not be effective in these settings.Januet has not been studied in patients with a history of pancreatitis. It is unknown whether patients with a history of pancreatitis are at increased risk for the development of pancreatitis while using Januet.
Autorisation dato:
2009-01-01
